0001601485-24-000017.txt : 20240329 0001601485-24-000017.hdr.sgml : 20240329 20240328181520 ACCESSION NUMBER: 0001601485-24-000017 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240328 EFFECTIVENESS DATE: 20240329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elicio Therapeutics, Inc. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-509031 FILM NUMBER: 24801054 BUSINESS ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (857) 209-0050 MAIL ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Angion Biomedica Corp. DATE OF NAME CHANGE: 20140228 D 1 primary_doc.xml X0708 D LIVE 0001601485 Elicio Therapeutics, Inc. 451 D STREET, 5TH FLOOR BOSTON MA MASSACHUSETTS 02210 (857) 209-0050 DELAWARE Angion Biomedica Corp. Corporation true Robert Connelly 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Director Peter DeMuth 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Christopher Haqq 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Brian Piekos 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Julian Adams 451 D Street Boston MA MASSACHUSETTS 02210 Director Carol Ashe 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Yekaterina Chudnovsky 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Allen Nissenson 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Robert Ruffolo 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Jay Venkatesan 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Karen Wilson 451 D Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Biotechnology Decline to Disclose 06b false 2024-03-19 false true true false 0 6000000 6000000 0 false 1 0 0 0 false Elicio Therapeutics, Inc. /s/ Robert Connelly Robert Connelly CEO 2024-03-28